Clinical trial
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
NCT00004041 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00004041 |
|---|---|
| Title | Gene Therapy in Treating Patients With Recurrent Malignant Gliomas |
| Official title | Phase I Trial of Adenovirus-Mediated Wild-Type P53 Gene Therapy for Malignant Gliomas |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological, Procedure |
| Interventions | Ad5CMV-p53 gene, conventional surgery |
| Start date | Feb 25, 1999 |
| Primary completion | Jul 22, 2002 |
| Completion | Jul 1, 2003 |
| First posted | Jul 19, 2004 |
| Last update posted | Jun 27, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: